Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/09/2023 | 40.66% | Raymond James | $8.25 → $5.5 | Maintains | Outperform |
11/07/2023 | 91.82% | JP Morgan | $9 → $7.5 | Maintains | Overweight |
09/12/2023 | 206.91% | Benchmark | → $12 | Reiterates | Buy → Buy |
08/18/2023 | — | William Blair | Initiates Coverage On | → Outperform | |
08/11/2023 | 155.75% | Truist Securities | $8 → $10 | Maintains | Buy |
08/11/2023 | 155.75% | Canaccord Genuity | $6 → $10 | Maintains | Buy |
08/11/2023 | 111% | Raymond James | $6.25 → $8.25 | Maintains | Outperform |
08/11/2023 | 130.18% | Telsey Advisory Group | $7.5 → $9 | Maintains | Outperform |
08/07/2023 | 53.45% | Benchmark | → $6 | Reiterates | Buy → Buy |
08/07/2023 | 91.82% | Telsey Advisory Group | $3 → $7.5 | Upgrades | Market Perform → Outperform |
07/18/2023 | 59.85% | Raymond James | $3.75 → $6.25 | Maintains | Outperform |
07/14/2023 | 104.6% | Truist Securities | $5 → $8 | Maintains | Buy |
07/12/2023 | 53.45% | B of A Securities | $3.25 → $6 | Upgrades | Neutral → Buy |
07/12/2023 | 79.03% | JP Morgan | → $7 | Upgrades | Neutral → Overweight |
07/11/2023 | 53.45% | Benchmark | → $6 | Reiterates | Buy → Buy |
07/06/2023 | 53.45% | Canaccord Genuity | $5 → $6 | Maintains | Buy |
05/18/2023 | 53.45% | Benchmark | → $6 | Reiterates | Buy → Buy |
05/18/2023 | -23.27% | Telsey Advisory Group | → $3 | Reiterates | Market Perform → Market Perform |
05/12/2023 | -4.09% | Raymond James | $3.5 → $3.75 | Maintains | Outperform |
05/12/2023 | -23.27% | Telsey Advisory Group | $2.5 → $3 | Maintains | Market Perform |
05/09/2023 | -36.06% | Telsey Advisory Group | $3 → $2.5 | Reiterates | → Market Perform |
03/30/2023 | 27.88% | Canaccord Genuity | → $5 | Initiates Coverage On | → Buy |
03/10/2023 | -10.49% | Raymond James | $3 → $3.5 | Maintains | Outperform |
03/10/2023 | -23.27% | Telsey Advisory Group | → $3 | Reiterates | → Market Perform |
02/28/2023 | -48.85% | DA Davidson | $4 → $2 | Downgrades | Buy → Neutral |
02/13/2023 | -23.27% | Raymond James | $5 → $3 | Maintains | Outperform |
02/07/2023 | 53.45% | Benchmark | $8 → $6 | Maintains | Buy |
02/07/2023 | -23.27% | Telsey Advisory Group | $5 → $3 | Downgrades | Outperform → Market Perform |
02/03/2023 | -10.49% | B of A Securities | → $3.5 | Maintains | Neutral |
12/13/2022 | 27.88% | Telsey Advisory Group | $7 → $5 | Maintains | Outperform |
11/15/2022 | 27.88% | Raymond James | $9 → $5 | Maintains | Outperform |
11/15/2022 | 79.03% | Telsey Advisory Group | $9 → $7 | Maintains | Outperform |
10/05/2022 | 104.6% | Truist Securities | $10 → $8 | Maintains | Buy |
08/12/2022 | 155.75% | Truist Securities | $15 → $10 | Maintains | Buy |
08/12/2022 | 130.18% | Raymond James | $10 → $9 | Maintains | Outperform |
08/12/2022 | 130.18% | Telsey Advisory Group | $13 → $9 | Maintains | Outperform |
08/09/2022 | 155.75% | Imperial Capital | → $10 | Initiates Coverage On | → Outperform |
08/01/2022 | 155.75% | Raymond James | $14 → $10 | Maintains | Outperform |
07/29/2022 | 130.18% | B of A Securities | $13 → $9 | Downgrades | Buy → Neutral |
07/29/2022 | 232.48% | Telsey Advisory Group | $16 → $13 | Maintains | Outperform |
07/29/2022 | 155.75% | Jefferies | $18 → $10 | Downgrades | Buy → Hold |
07/29/2022 | 130.18% | JP Morgan | $14 → $9 | Downgrades | Overweight → Neutral |
06/28/2022 | 258.06% | JP Morgan | → $14 | Initiates Coverage On | → Overweight |
06/22/2022 | 232.48% | B of A Securities | → $13 | Initiates Coverage On | → Buy |
05/13/2022 | 258.06% | Raymond James | $14.5 → $14 | Maintains | Outperform |
03/04/2022 | 309.21% | Telsey Advisory Group | $15 → $16 | Maintains | Outperform |
01/14/2022 | 270.84% | Raymond James | $14 → $14.5 | Maintains | Outperform |
01/11/2022 | 309.21% | Telsey Advisory Group | $15 → $16 | Maintains | Outperform |
11/11/2021 | 258.06% | Raymond James | $13 → $14 | Maintains | Outperform |
09/09/2021 | 283.63% | Truist Securities | → $15 | Initiates Coverage On | → Buy |
08/19/2021 | 360.36% | Jefferies | → $18 | Initiates Coverage On | → Buy |
08/16/2021 | 232.48% | Raymond James | → $13 | Initiates Coverage On | → Outperform |
08/12/2021 | — | William Blair | Initiates Coverage On | → Outperform |
What is the target price for Holley (HLLY)?
The latest price target for Holley (NYSE: HLLY) was reported by Raymond James on November 9, 2023. The analyst firm set a price target for $5.50 expecting HLLY to rise to within 12 months (a possible 40.66% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Holley (HLLY)?
The latest analyst rating for Holley (NYSE: HLLY) was provided by Raymond James, and Holley maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Holley (HLLY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Holley, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Holley was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Holley (HLLY) correct?
While ratings are subjective and will change, the latest Holley (HLLY) rating was a maintained with a price target of $8.25 to $5.50. The current price Holley (HLLY) is trading at is $3.91, which is out of the analyst's predicted range.